Drug therapy in patients with severe forms of sickle cell anemia: A nonrandomized clinical trial of combining l-carnitine with hydroxycarbamide therapy-Reference-Cited by-同舟云学术

Drug therapy in patients with severe forms of sickle cell anemia: A nonrandomized clinical trial of combining l-carnitine with hydroxycarbamide therapy

Published:2022 Issue:4 Volume:13 Page:237
ISSN:1658-5127
Container-title:Journal of Applied Hematology
language:en
Short-container-title:J Appl Hematol

Author:

A. Khaled SafaaA,M. Ashry IsraaE

Publisher

Medknow

Subject

Hematology

Reference34 articles.

1. Sickle-cell disease;Rees;Lancet,2010

2. Steinberg MH. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. New York: Cambridge University Press; 2009. p. 826.

3. Global burden of sickle cell anaemia in children under five, 2010-2050: Modelling based on demographics, excess mortality, and interventions;Piel;PLoS Med,2013

4. High prevalence of haemoglobin S in the closed Egyptian community of Siwa Oasis;Moez;J Clin Pathol,2016

5. Current trends in the management of sickle cell disease: An overview;Isoa;Benin J Postgrad Med,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explorations of structural and electronic features of an enhanced iron-doped boron nitride nanocage for adsorbing/sensing functions of the hydroxyurea anticancer drug delivery under density functional theory calculations;Physica B: Condensed Matter;2023-12

2. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment;Haematologica;2023-07-13

3. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment;2023-04-06